Join to access to all OVN content. Join for Free

Results for 'hybrid interaction post-COVID'

Tom Caravela

Where Did My Interview Go Wrong?

Apr 23^rd • 1 min read

Tom Caravela

Mastering the First Impression

Jan 28^th • 2 mins read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 16^th • 2 mins read

Tom Caravela

MSL Evolution: New Trends and Titles That May Emerge

Apr 4^th • 1 min read

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 19^th • 8 mins read

Bridget Rasmusson

Positioning Yourself to Become an MSL in 2022

Dec 20^th • 10 mins read

Jingjing Yu, Isabelle Ragueneau-Majlessi

In Vitro-to-In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018

Jan 24^th • 12 mins read

Laleh Amiri-Kordestani & Richard Pazdur

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

Jan 28^th • 4 mins read

Emerson Y. Chen, MD, Vikram Raghunathan, MD, Vinay Prasad, MD, MPH

An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate

May 27^th • 5 mins read

Stephanie Faucette, Santosh Wagh, Ashit Trivedi, Karthik Venkatakrishnan, Neeraj Gupta

Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development

Mar 10^th • 15 mins read

Related Topics

See More Topics